Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2−, node-positive, high-risk early breast cancer in Italy

por Davie, Alison, Traoré, Sory, Giovannitti, Massimo, Pompilio, Giuseppe, Lambton, Mark, Cakar, Esra, Chatterjee, Anuja
Publicado 2023

Care bundles for acute kidney injury: a balanced accounting of the impact of implementation in an acute medical unit

por Logan, Rachael, Davey, Peter, Davie, Alison, Grant, Suzanne, Tully, Vicki, Valluri, Achyut, Bell, Samira
Publicado 2018

Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration

por Levy, Adrian R., Szabo, Shelagh, Briggs, Andrew, Pleil, Andreas, Davie, Alison, Zlateva, Gergana, Javitt, Jonathan
Publicado 2009

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

por Davie, Alison, Carter, Gebra Cuyun, Rider, Alex, Pike, James, Lewis, Katie, Bailey, Abigail, Price, Gregory L., Ringeisen, Francois, Pivot, Xavier
Publicado 2020